nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Beta-Blockers in Acute Heart Failure
|
Jondeau, Guillaume |
|
2015 |
3 |
8 |
p. 654-656 3 p. |
artikel |
2 |
Combined Free Light Chains Are Novel Predictors of Prognosis in Heart Failure
|
Jackson, Colette E. |
|
2015 |
3 |
8 |
p. 618-625 8 p. |
artikel |
3 |
Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure
|
Prins, Kurt W. |
|
2015 |
3 |
8 |
p. 647-653 7 p. |
artikel |
4 |
Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure
|
Vodovar, Nicolas |
|
2015 |
3 |
8 |
p. 629-636 8 p. |
artikel |
5 |
Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical Trials
|
Rush, Christopher J. |
|
2015 |
3 |
8 |
p. 603-614 12 p. |
artikel |
6 |
Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries
|
Bloomfield, Gerald S. |
|
2015 |
3 |
8 |
p. 579-590 12 p. |
artikel |
7 |
Inside This Issue
|
|
|
2015 |
3 |
8 |
p. A17-A20 nvt p. |
artikel |
8 |
Light Chains and the Failing Heart
|
Januzzi Jr., James L. |
|
2015 |
3 |
8 |
p. 626-628 3 p. |
artikel |
9 |
Neprilysin
|
Seronde, Marie-France |
|
2015 |
3 |
8 |
p. 645-646 2 p. |
artikel |
10 |
Neprilysin in Heart Failure
|
Bayés-Genís, Antoni |
|
2015 |
3 |
8 |
p. 637-640 4 p. |
artikel |
11 |
Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals
|
Secemsky, Eric A. |
|
2015 |
3 |
8 |
p. 591-599 9 p. |
artikel |
12 |
Perhexiline, Cardiac Energetics, and Heart Failure
|
Davogustto, Giovanni |
|
2015 |
3 |
8 |
p. 659-660 2 p. |
artikel |
13 |
Prognostic Value and Kinetics of Soluble Neprilysin in Acute Heart Failure
|
Bayés-Genís, Antoni |
|
2015 |
3 |
8 |
p. 641-644 4 p. |
artikel |
14 |
Reply
|
Beadle, Roger M. |
|
2015 |
3 |
8 |
p. 660- 1 p. |
artikel |
15 |
The Broad Spectrum of HIV-Related Cardiovascular Disease ∗
|
Shah, Monica R. |
|
2015 |
3 |
8 |
p. 600-602 3 p. |
artikel |
16 |
The Globalization of Heart Failure Research
|
O’Connor, Christopher M. |
|
2015 |
3 |
8 |
p. 657-658 2 p. |
artikel |
17 |
The Ongoing Evolution of Optimal Clinical Endpoints for Heart Failure Trials ∗
|
Krum, Henry |
|
2015 |
3 |
8 |
p. 615-617 3 p. |
artikel |